Company Search:
Advanced Search
Sponsored Links
Shire PLC - ADR Company Snapshot
Shire PLC operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shire PLC with three other companies in this sector in the United States: Allergan plc (2016 sales of $14.57 billion of which 41% was US Medical Aesthetics), Mylan NV ($11.08 billion ), and Celgene Corporation ($11.23 billion of which 100% was Biopharmaceuticals).

Sales Analysis. During the year ended December of 2016, sales at Shire PLC were $11.40 billion. This is an increase of 77.6% versus 2015, when the company's sales were $6.42 billion. This was the fifth consecutive year of sales increases at Shire PLC (and since 2011, sales have increased a total of 167%).
  Stock Performance Chart for Shire PLC - ADR
  Stock Data: Recent Stock Performance:
  Current Price (12/15/2017): 151.27
(Figures in U.S. Dollars)
1 Week 2.2%   13 Weeks 2.6%  
4 Weeks -4.5%   52 Weeks -12.1%  
Shire PLC - ADR Key Data:
  Ticker: SHPG Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 11,396,638,079
(Year Ending Jan 2017).
Employees: 23,906
  Currency: U.S. Dollars Market Cap: 45,759,175,000
  Fiscal Yr Ends: December Shares Outstanding: 302,500,000
  Share Type: Ordinary Closely Held Shares: 127,165
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.